MM&M ON TWITTER



The Mobile Guide
Trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Salary Survey



 It's YOUR program, so YOU pick the color. Click here now to vote.

The Agency Gallery


White Papers

SUBSCRIBE TO MM&M


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Novo launches new consumer ads for Victoza

Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product's ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ads and a refurbished website, and marks the first consumer push for the brand since its approval in January.
 

Lysteda TV ads make some networks squeamish

Ferring Pharmaceuticals is launching its first branded TV ad with spots for its Lysteda treatment for heavy menstrual bleeding. The company had to soothe some network execs who at first balked at the ad's blunt talk of the condition.
 

Walgreens partners with Epocrates to highlight drug rebates

Walgreens is hoping physicians will consider its "Prescription Savings Club" list of over 8,000 brand and generic drugs before deciding which script to write for underinsured or cash-strapped patients. Epocrates will provide point of care access to the list via mobile device starting today.
 

From our Sponsor




Essential in Print. Essential Online.

Physicians call the New England Journal of Medicine one of their most essential journals in print.

They also call NEJM.org their most essential website. Completely redesigned, it brings you new ad sizes and specialty targeting to help you reach your most important prospects.

Find out more at nejmadsales.org

In Brief

People news: AbelsonTaylor

AbelsonTaylor named Nancy Drescher SVP, director of client services.
 

Company news: Boehringer Ingelheim

Boehringer Ingelheim won FDA approval for blood thinner Pradaxa (dabigatran) to prevent stroke in patients with atrial fibrillation (AFib), beating two other potential warfarin replacements to the US market.
 

LATEST FEATURES

Patient Marketing Report: Thinking Past the Pill

Pfizer is investing heavily in adherence, putting patient support programs on equal footing with some of its drugs, Matthew Arnold reports
 

MM&M Therapeutic Focus: Oncology

Targeted cancer therapies and chemotherapeutic products are a $20 billion category. Expanding indications for marketed products and a bulging pipeline should keep this segment growing for the foreseeable future, analysts say.
 

Leadership Exchange: How Do You Measure Patient Programs?

Industry experts discuss definitions of success in patient education—and ways to measure its value. James Chase takes the chair
 

Professional Ad Report: On the Up

Something good's going on. Professional journal advertising has rebounded in spectacular fashion in the first-half 2010. James Chase reports on the biggest advertisers and most advertised brands
 

Headliner: Grassley's Ghostwriter Exits Hill

When Paul Thacker announced in July that he was leaving the Senate Finance Committee, you could practically hear drug company lobbyists whooping for joy.
 

2010/11 PMD




The 2010/11 PMD is the contact resource of choice. Over 17,000 business connections, 4,000 companies and 5,000 new industry names added since the last edition.
Get connected today and order your personal copy.



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.